Published 2 years ago

AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Summary by Ground News

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its second quarter 2022 financial results. DSUVIA sales volume growth of 133% compared to Q2 2021. EU launch of DZUVEO in the third quarter. Annual savings of $9 million beginning in June 2022.

0 Articles

All

Left

Center

Right

Financial Post

Sienna Senior Living Inc. Reports Second Quarter 2022 Financial Results and Unveils its New Purpose and Vision

Change to Sienna’s Board of DirectorsRead More

2 years ago·Canada

Read Full Article

Business Wire

Microvast Reports Second Quarter 2022 Financial Results

STAFFORD, Texas--(BUSINESS WIRE)--Aug 11, 2022-

2 years ago·Crystal River, United States

Read Full Article

The Verge

Rivian reports more losses in the second quarter of 2022

Rivian generated $364 million in revenue.

2 years ago·United States

Read Full Article

PR Newswire

AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Advanced Niyad™ supply chain development with a focus on obtaining an Emergency Use Authorization in 2023 $0.6 million net revenue in Q2 2022; fifth...

2 years ago·United States

Read Full Article

Globe Newswire

Phunware Reports Record Second Quarter 2022 Financial Results

AUSTIN, Texas, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or the “Company”), a fully-integrated enterprise cloud...

2 years ago

Read Full Article

Newswire

Glass House Brands Reports Second Quarter 2022 Financial Results

SoCal Farm first harvest was in May, and Glass House single month July production was almost equal to output for all of Q2 -Record low quarterly cost per...

2 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.